AB065. EP4 antagonist suppresses bone metastasis in prostate cancer

BACKGROUND: Bone metastasis is one of the most common complications in clinical intractable castration-resistant prostate cancer (CRPC) and advanced prostate cancer period. The invasion ability of cancer cells was thought to have important relationship with the potential of cancer metastasis. EP4 re...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Song, Ge, Jing-Ping, Zhang, Zheng-Yu, Zhou, Wen-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Printed Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565529/
http://dx.doi.org/10.21037/tau.2017.s065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565529/
http://dx.doi.org/10.21037/tau.2017.s065

Ejemplares similares